Loading...
Loading...
ETON| Name | Value |
|---|---|
| Revenues | 8,498.0K |
| Cost of Revenue | 2,138.0K |
| Gross Profit | 6,360.0K |
| Operating Expense | 5,298.0K |
| Operating I/L | 810.0K |
| Other Income/Expense | 102.0K |
| Interest Income | 0.0K |
| Pretax | 912.0K |
| Income Tax Expense | -102.0K |
| Net Income/Loss | 912.0K |
Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes pharmaceutical products for rare diseases. Their product portfolio includes Biorphen, Carglumic Acid, Rezipres, Alkindi Sprinkle, EPRONTIA, Alaway Preservative Free, Zonisamide Oral Suspension, Lamotrigine for Oral Suspension, cysteine injection, dehydrated alcohol injection, and Zeneo hydrocortisone autoinjector. These products cater to various medical needs such as hypotension, adrenocortical insufficiency, allergic conjunctivitis, and seizures. Eton Pharmaceuticals generates revenue by selling these pharmaceutical products to healthcare providers and patients in need of specialized treatments for rare diseases.
